Literature DB >> 19139865

Glutamate and capsaicin-induced pain, hyperalgesia and modulatory interactions in human tendon tissue.

William Gibson1, Lars Arendt-Nielsen, Barry J Sessle, Thomas Graven-Nielsen.   

Abstract

Experimental glutamate and capsaicin-induced pain has not been described in tendon tissue despite the implications of addressing these receptors in pain management strategies. This study investigated pain induction and modulatory interactions by injecting glutamate (0.5 ml, 1 M) and capsaicin (0.5 ml, 5 microg, 33 microM) to human tendon tissue. Following the initial glutamate or capsaicin injection, a second injection of either glutamate (following capsaicin), capsaicin (following glutamate) or hypertonic saline (after both glutamate and capsaicin) was given. Twelve male volunteers participated. Subjects had four sequences of injections to tibialis anterior tendon over two sessions 1 week apart. Pain intensity responses were scored on a visual analogue scale (VAS). Pressure pain thresholds (PPTs) were assessed before, during and after pain induction. Capsaicin caused significantly higher peak pain scores compared to glutamate (P < 0.003) whilst glutamate pain was of significantly longer duration (P < 0.0003). Capsaicin following glutamate resulted in significantly higher average VAS scores 180-450 s after injection compared to capsaicin as primary injection (P < 0.05). PPTs were significantly reduced during capsaicin pain (72 +/- 5 and 80 +/- 6% of pre-pain values at the injection site and 2 cm proximal, P < 0.002). Following capsaicin, hypertonic saline and glutamate showed significant reductions in PPT at the same sites and to a similar degree compared to baseline (P < 0.002). The results indicate in tendon tissue a facilitation of response to capsaicin injection following glutamate injection. PPTs were only reliably reduced by capsaicin injection. These results emphasize the possible importance of peripheral glutamate receptor antagonists in pain management in musculoskeletal conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139865     DOI: 10.1007/s00221-008-1683-3

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  46 in total

1.  Peripheral group I metabotropic glutamate receptors modulate nociception in mice.

Authors:  G Bhave; F Karim; S M Carlton; R W Gereau
Journal:  Nat Neurosci       Date:  2001-04       Impact factor: 24.884

Review 2.  Metabotropic glutamate receptors--important modulators of nociception and pain behavior.

Authors:  Volker Neugebauer
Journal:  Pain       Date:  2002-07       Impact factor: 6.961

3.  Segmental and plurisegmental modulation of pressure pain thresholds during static muscle contractions in healthy individuals.

Authors:  Eva Kosek; Lena Lundberg
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

4.  Glutamate-induced sensitization of rat masseter muscle fibers.

Authors:  B E Cairns; G Gambarota; P Svensson; L Arendt-Nielsen; C B Berde
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

5.  Experimentally induced muscle pain induces hypoalgesia in heterotopic deep tissues, but not in homotopic deep tissues.

Authors:  T Graven-Nielsen; V Babenko; P Svensson; L Arendt-Nielsen
Journal:  Brain Res       Date:  1998-03-23       Impact factor: 3.252

6.  Peripheral lidocaine but not ketamine inhibits capsaicin-induced hyperalgesia in humans.

Authors:  H Gottrup; F W Bach; L Arendt-Nielsen; T S Jensen
Journal:  Br J Anaesth       Date:  2000-10       Impact factor: 9.166

7.  Interaction between vanilloid and glutamate receptors in the central modulation of nociception.

Authors:  Enza Palazzo; Vito de Novellis; Ida Marabese; Dario Cuomo; Francesca Rossi; Liberato Berrino; Francesco Rossi; Sabatino Maione
Journal:  Eur J Pharmacol       Date:  2002-03-29       Impact factor: 4.432

Review 8.  Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?

Authors:  Håkan Alfredson; Ronny Lorentzon
Journal:  Curr Drug Targets       Date:  2002-02       Impact factor: 3.465

9.  Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery.

Authors:  R E Coggeshall; S M Carlton
Journal:  J Comp Neurol       Date:  1998-02-02       Impact factor: 3.215

10.  AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.

Authors:  C N Sang; M P Hostetter; R H Gracely; A S Chappell; D D Schoepp; G Lee; S Whitcup; R Caruso; M B Max
Journal:  Anesthesiology       Date:  1998-11       Impact factor: 7.892

View more
  9 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Changes in correlation between spontaneous activity of dorsal horn neurones lead to differential recruitment of inhibitory pathways in the cat spinal cord.

Authors:  D Chávez; E Rodríguez; I Jiménez; P Rudomin
Journal:  J Physiol       Date:  2012-01-23       Impact factor: 5.182

3.  Functional interactions between NMDA receptors and TRPV1 in trigeminal sensory neurons mediate mechanical hyperalgesia in the rat masseter muscle.

Authors:  Jongseok Lee; Jami L Saloman; Gustave Weiland; Q-Schick Auh; Man-Kyo Chung; Jin Y Ro
Journal:  Pain       Date:  2012-05-19       Impact factor: 6.961

Review 4.  Cancer-induced oxidative stress and pain.

Authors:  Mina G Nashed; Matthew D Balenko; Gurmit Singh
Journal:  Curr Pain Headache Rep       Date:  2014-01

5.  Basic aspects of musculoskeletal pain: from acute to chronic pain.

Authors:  Lars Arendt-Nielsen; César Fernández-de-Las-Peñas; Thomas Graven-Nielsen
Journal:  J Man Manip Ther       Date:  2011-11

6.  Serum levels of oxylipins in achilles tendinopathy: an exploratory study.

Authors:  Sandra Gouveia-Figueira; Malin L Nording; Jamie E Gaida; Sture Forsgren; Håkan Alfredson; Christopher J Fowler
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  Marked innervation but also signs of nerve degeneration in between the Achilles and plantaris tendons and presence of innervation within the plantaris tendon in midportion Achilles tendinopathy.

Authors:  C Spang; V M Harandi; H Alfredson; S Forsgren
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

Review 8.  Review: Emerging concepts in the pathogenesis of tendinopathy.

Authors:  Benjamin J F Dean; Stephanie G Dakin; Neal L Millar; Andrew J Carr
Journal:  Surgeon       Date:  2017-06-12       Impact factor: 2.392

9.  Glutamate signaling through the NMDA receptor reduces the expression of scleraxis in plantaris tendon derived cells.

Authors:  Christoph Spang; Ludvig J Backman; Sandrine Le Roux; Jialin Chen; Patrik Danielson
Journal:  BMC Musculoskelet Disord       Date:  2017-05-25       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.